ダイアグノスティクス

our commitment
to addressing the
covid-19 pandemic

at abbott, the health and well-being of our customers and communities is our priority.

For more than 130 years, we've put science and innovation to work - to create more possibilities for more people through the power of health. We adapt and respond quickly to changes in the world around us to deliver better solutions to help people live their best lives.

That commitment remains as we work to ensure continued supply, service and support to our valued customers and healthcare professionals during these times of global uncertainty.

Abbott covid-19 product availability

Announcing sars-cov-2
immunoassays

Serology testing is an important next step in combating the
covid-19 pandemic. our automated lab-based test detects the
human antibody response, igG, to the novel coronavirus.
antibody testing provides additional options to test patients
and conduct covid-19 research.

Learn more

abbott realtime sars-cov-2
assay now available

to help with the need for automated, high volume covid-19 testing
abbott has obtained ce marking on its realtime sars-cov-2 assay
for use on the m2000 system. we are accelerating production in an
effort to meet the needs of our customers worldwide.

Learn more

patient monitoring

Monitoring in the Lab

With increased patient volume at healthcare facilities and the associated scarcity of
resources, evaluating disease severity can help optimize resource utilization by
ensuring that the appropriate level of treatment is provided.

HEMATOLOGY

The complete blood count (CBC), one of the most commonly performed tests
in the world, can be a fast and cost-effective way to support patient assessments.

Learn More

Blood gas monitoring at the
point-of-care

healthcare facilities are being challenged in increased patient
volume and the need for continued monitoring of blood gases
in respiratory care patients. Testing with portable, handheld
i‑STAT analyzers facilitates real-time decisions to optimize care.

learn more

abbott covid-19 information

helping to prevent
the spread

abbott is on the frontlines of the covid-19
response with critical tests that will help
protect our communities.

learn more

additional covid-19 resources

As the situation concerning COVID-19 changes day to day, the following links may help you stay up-to-date on the latest developments.

Join the conversation

Follow the Abbott Diagnostics LinkedIn channel for the latest news from our company and within the in vitro diagnostics industry.

The Abbott Point of Care i-STAT system does not offer any test cartridges for the diagnosis of COVID-19.

ダイアグノスティクス

ダイアグノスティクス

our commitment
to addressing the
covid-19 pandemic

at abbott, the health and well-being of our customers and communities is our priority.

Abbott covid-19 product availability

Announcing sars-cov-2
immunoassays

Serology testing is an important next step in combating the
covid-19 pandemic. our automated lab-based test detects the
human antibody response, igG, to the novel coronavirus.
antibody testing provides additional options to test patients
and conduct covid-19 research.

abbott realtime sars-cov-2
assay now available

to help with the need for automated, high volume covid-19 testing
abbott has obtained ce marking on its realtime sars-cov-2 assay
for use on the m2000 system. we are accelerating production in an
effort to meet the needs of our customers worldwide.

patient monitoring

Monitoring in the Lab

HEMATOLOGY

Blood gas monitoring at the
point-of-care

healthcare facilities are being challenged in increased patient
volume and the need for continued monitoring of blood gases
in respiratory care patients. Testing with portable, handheld
i‑STAT analyzers facilitates real-time decisions to optimize care.

abbott covid-19 information

helping to prevent
the spread

abbott is on the frontlines of the covid-19
response with critical tests that will help
protect our communities.

additional covid-19 resources

world health organization
(WHO)

international federation of clinical chemistry and laboratory medicine (ifcc)

american association for clinical chemistry
(aacc)

center for disease
control
(cdc)

Join the conversation

アボットのウェブサイトから第三者のウェブサイトに移動しようとしています。

続行してこのウェブサイトを離れてもよろしいですか？

アボットの国または地域に固有のウェブサイトに入ろうとしています。

続行してこのウェブサイトに入ってもよろしいですか？

アボットの国または地域に固有のウェブサイトに入ろうとしています。

続行してこのウェブサイトに入ってもよろしいですか？

DIAGNOSTICS ウェブサイトを終了しますか。

our commitment to addressing the covid-19 pandemic

at abbott, the health and well-being of our customers and communities is our priority.

Abbott covid-19 product availability

Announcing sars-cov-2 immunoassays

Serology testing is an important next step in combating the covid-19 pandemic. our automated lab-based test detects the human antibody response, igG, to the novel coronavirus. antibody testing provides additional options to test patients and conduct covid-19 research.

abbott realtime sars-cov-2 assay now available

to help with the need for automated, high volume covid-19 testing abbott has obtained ce marking on its realtime sars-cov-2 assay for use on the m2000 system. we are accelerating production in an effort to meet the needs of our customers worldwide.

patient monitoring

Monitoring in the Lab

HEMATOLOGY

Blood gas monitoring at the point-of-care

healthcare facilities are being challenged in increased patientvolume and the need for continued monitoring of blood gasesin respiratory care patients. Testing with portable, handheld i‑STAT analyzers facilitates real-time decisions to optimize care.

abbott covid-19 information

helping to preventthe spread

abbott is on the frontlines of the covid-19 response with critical tests that will help protect our communities.

additional covid-19 resources

world health organization (WHO)

international federation of clinical chemistry and laboratory medicine (ifcc)

american association for clinical chemistry (aacc)

center for disease control(cdc)

Join the conversation

アボットのウェブサイトから第三者のウェブサイトに移動しようとしています。

続行してこのウェブサイトを離れてもよろしいですか？

アボットの国または地域に固有のウェブサイトに入ろうとしています。

続行してこのウェブサイトに入ってもよろしいですか？

アボットの国または地域に固有のウェブサイトに入ろうとしています。

続行してこのウェブサイトに入ってもよろしいですか？

DIAGNOSTICS ウェブサイトを終了しますか。

our commitment
to addressing the
covid-19 pandemic

Announcing sars-cov-2
immunoassays

Serology testing is an important next step in combating the
covid-19 pandemic. our automated lab-based test detects the
human antibody response, igG, to the novel coronavirus.
antibody testing provides additional options to test patients
and conduct covid-19 research.

abbott realtime sars-cov-2
assay now available

to help with the need for automated, high volume covid-19 testing
abbott has obtained ce marking on its realtime sars-cov-2 assay
for use on the m2000 system. we are accelerating production in an
effort to meet the needs of our customers worldwide.

Blood gas monitoring at the
point-of-care

healthcare facilities are being challenged in increased patient
volume and the need for continued monitoring of blood gases
in respiratory care patients. Testing with portable, handheld
i‑STAT analyzers facilitates real-time decisions to optimize care.

helping to prevent
the spread

abbott is on the frontlines of the covid-19
response with critical tests that will help
protect our communities.

world health organization
(WHO)

american association for clinical chemistry
(aacc)

center for disease
control
(cdc)